TRAJENTA DUO 2.5/500 MG 10 TABLETS | Linagliptin Metformin
TRAJENTA DUO 2.5 MG/500 MG 10 TABLETS contain Linagliptin 2.5 mg and Metformin 500 mg, a prescription combination medicine used with diet and exercise to improve blood sugar control in type 2 diabetes.
TRAJENTA DUO 2.5 MG/500 MG 10 TABLETS
TRAJENTA DUO 2.5/500 MG TABLETS (Linagliptin 2.5 mg + Metformin 500 mg): Comprehensive Guide and Benefits
Introduction to TRAJENTA DUO 2.5/500 MG TABLETS
DPP-4 Inhibitor and Biguanide Combination for Type 2 Diabetes Management
TRAJENTA DUO 2.5 MG/500 MG TABLETS contain a combination of Linagliptin 2.5 mg and Metformin Hydrochloride 500 mg. It is an oral antidiabetic medicine prescribed for adults with type 2 diabetes mellitus when treatment with both medicines is considered appropriate.
This combination provides dual action: Metformin helps reduce glucose production by the liver and improves insulin sensitivity, while Linagliptin helps increase glucose-dependent insulin release by inhibiting the DPP-4 enzyme.
Prescription Status: Prescription-only medicine.
Key Benefits of TRAJENTA DUO 2.5/500 MG TABLETS
Helps improve blood glucose control in adults with type 2 diabetes.
Supports better fasting and post-meal blood sugar regulation.
Improves insulin sensitivity through Metformin action.
Enhances natural insulin response through Linagliptin.
Can be used along with diet and exercise for diabetes management.
Composition
Active Ingredients:
Linagliptin – 2.5 mg
Metformin Hydrochloride – 500 mg
Dosage Form:
Oral Film-Coated Tablet
Drug Class:
DPP-4 Inhibitor (Linagliptin)
Biguanide Antidiabetic Agent (Metformin)
Manufacturer/Marketer:
Boehringer Ingelheim
How TRAJENTA DUO 2.5/500 MG Works
TRAJENTA DUO combines two medicines with complementary mechanisms:
Linagliptin
Blocks the DPP-4 enzyme.
Increases incretin hormone activity.
Enhances insulin release when blood glucose levels are elevated.
Helps reduce glucagon secretion, which lowers excess glucose production.
Metformin
Reduces glucose production in the liver.
Improves the body’s response to insulin.
Helps decrease intestinal absorption of glucose.
Together, these actions help maintain improved blood sugar levels.
Usage Instructions
Take TRAJENTA DUO 2.5/500 MG TABLETS exactly as prescribed by your doctor.
Usually taken with or after food to reduce stomach discomfort.
Swallow the tablet whole with water.
Do not crush, chew, or break the tablet.
Take it at the same time each day for consistent results.
Do not stop treatment without medical advice.
Medicinal Advantages
Type 2 Diabetes Management
Helps control elevated blood glucose levels.
Supports long-term diabetes management along with lifestyle modifications.
Improved Insulin Response
Helps the body use insulin more effectively.
Supports glucose regulation without directly forcing insulin release at low glucose levels.
Combination Therapy Benefit
Provides two complementary mechanisms in a single tablet, improving convenience for eligible patients.
Mechanism of Action
Linagliptin inhibits DPP-4, preventing the breakdown of incretin hormones such as GLP-1 and GIP. This increases insulin secretion in response to elevated blood glucose and reduces glucagon release.
Metformin activates pathways that decrease hepatic glucose production and improve insulin sensitivity, helping reduce overall blood glucose levels.
Off-Label Uses
Linagliptin and Metformin combinations may be evaluated by healthcare professionals for other metabolic conditions based on individual clinical assessment.
Any off-label use should only be considered under specialist supervision.
Expert Advice
Follow a balanced diet and regular exercise plan along with medication.
Monitor blood glucose levels as advised.
Inform your doctor about kidney or liver problems before starting treatment.
Maintain regular medical check-ups.
Report symptoms of low blood sugar if TRAJENTA DUO is combined with insulin or sulfonylureas.
Precautions
Kidney Disease
Metformin-containing medicines require caution in patients with kidney impairment. Kidney function should be assessed before and during treatment.
Liver Disease
Inform your doctor about liver problems before taking TRAJENTA DUO.
Alcohol Consumption
Excessive alcohol intake may increase the risk of serious side effects associated with Metformin.
Pregnancy and Breastfeeding
Consult your healthcare provider before using TRAJENTA DUO during pregnancy or breastfeeding.
Drug Interactions
Inform your doctor if you are taking:
Other diabetes medicines.
Insulin.
Sulfonylureas.
Diuretics.
Corticosteroids.
Medicines affecting kidney function.
Contrast dyes used in imaging procedures.
Possible Side Effects
Common side effects may include:
Nausea.
Vomiting.
Diarrhea.
Stomach discomfort.
Headache.
Dizziness.
Fatigue.
Skin rash.
Seek medical advice if you experience severe abdominal pain, persistent vomiting, allergic reactions, or unusual weakness.
Storage Instructions
Store below 30°C.
Keep tablets in the original packaging.
Protect from moisture and direct sunlight.
Keep out of reach of children.
Frequently Asked Questions (FAQs)
Q: What is TRAJENTA DUO 2.5/500 MG used for?
A: TRAJENTA DUO is used with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.
Q: What are the ingredients in TRAJENTA DUO 2.5/500 MG?
A: Each tablet contains Linagliptin 2.5 mg and Metformin Hydrochloride 500 mg.
Q: Is TRAJENTA DUO insulin?
A: No. TRAJENTA DUO is an oral antidiabetic medicine containing a DPP-4 inhibitor and a biguanide.
Q: Can TRAJENTA DUO be stopped suddenly?
A: Do not stop this medicine without consulting your doctor, as blood sugar levels may become uncontrolled.
Q: Does TRAJENTA DUO cause low blood sugar?
A: Low blood sugar risk is generally lower when used alone but may increase when combined with insulin or sulfonylurea medicines.
Product Tags
TRAJENTA DUO 2.5/500 MG 10 TABLETS, Linagliptin 2.5 mg, Metformin 500 mg, DPP-4 Inhibitor Tablet, Type 2 Diabetes Medicine, Blood Sugar Control Tablet, Oral Antidiabetic Medicine, Diabetes Management Tablet, Boehringer Ingelheim.
